State Street’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-265,000
Closed -$292K 4722
2023
Q1
$292K Buy
265,000
+20,552
+8% +$13.4K ﹤0.01% 3936
2022
Q4
$148K Buy
244,448
+26,488
+12% +$17.6K ﹤0.01% 4234
2022
Q3
$170K Sell
217,960
-104,442
-32% -$78.6K ﹤0.01% 4216
2022
Q2
$240K Buy
322,402
+3,614
+1% +$3.1K ﹤0.01% 4118
2022
Q1
$335K Buy
318,788
+20,799
+7% +$18.4K ﹤0.01% 4200
2021
Q4
$286K Buy
297,989
+14,323
+5% +$19K ﹤0.01% 4200
2021
Q3
$414K Buy
283,666
+72,228
+34% +$133K ﹤0.01% 4052
2021
Q2
$496K Buy
211,438
+4,280
+2% +$10.6K ﹤0.01% 3857
2021
Q1
$574K Buy
207,158
+15,504
+8% +$51.4K ﹤0.01% 3719
2020
Q4
$387K Sell
191,654
-962
-0.5% -$3.04K ﹤0.01% 3679
2020
Q3
$645K Buy
+192,616
New +$750K ﹤0.01% 3533

Other funds holding TLSA

State Street's TLSA Position: Q2 2023 in Review

State Street sold out of Tiziana Life Sciences (TLSA) in Q2 2023, closing a stake of 265,000 shares — an estimated $292K sold.

State Street first reported a position in TLSA in Q3 2020 and held it in 11 quarters. The position peaked at $645K in Q3 2020. 20 funds tracked by Wall St. Rank hold TLSA as of Q2 2023.

  • State Street reported no remaining Tiziana Life Sciences position as of Q2 2023 after selling out during the quarter.
  • State Street sold 265,000 Tiziana Life Sciences shares in Q2 2023, an estimated $292K.
  • State Street first reported a position in Tiziana Life Sciences in Q3 2020 and held it in 11 quarters.
  • State Street's Tiziana Life Sciences position peaked at $645K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.